Bassel F. El‐Rayes - Publications, H-index & Citations

Bassel F. El‐Rayes

university of california san diego

63H指数

699论文数

1.6W被引数

收录论文 211

发表时间

Exosome mediated crosstalk in gastrointestinal cancers progression: special focus on Integrin β3 as a cargo 外泌体介导的胃肠道癌症进展中的串扰：特别关注整合素β3作为载体

Cancer Letters

IF10.1

2026-05-24

PREAI

Ganji Purnachandra Nagaraju; Sujith Sarvesh; Bassel F. El-Rayes

Pancreatic ductal adenocarcinoma: integrating molecular insights for targeted interventions 胰腺导管腺癌: 整合分子洞察进行靶向干预

Signal Transduction and Targeted Therapy

IF52.7

2026-05-05

OAAI

Ganji Purnachandra Nagaraju; Haasita Nellipudi; Chaithanya Ganji; Vaishnavi Kuppala; Swapna Priya Ganji; Seema Kumari; Batoul Farran; Mundla Srilatha; Rachael Guenter; Bassel F. El-Rayes

“Horses out of the barn”: pancreatic ductal adenocarcinoma frequently extends beyond the grossly visible tumour, requiring microscopic rectification for accurate T-staging “马匹走出谷仓”: 胰腺导管腺癌经常延伸到肉眼可见的肿瘤之外，需要显微镜矫正才能进行准确的T分期

Histopathology

IF4.1

2026-01-27

PREAI

Burcu Saka; Bahar Memis; Serdar Balci; Ipek Erbarut Seven; Burcin Pehlivanoglu; Pelin Bagci; Rohat Esmer; Zeynep Tarcan; Jeanette D Cheng; Shishir K Maithel; David A Kooby; Juan Sarmiento; Bassel El-Rayes; Michelle D Reid; Olca Basturk; N Volkan Adsay

A Phase Ib/II trial of XL888 (HSP90 inhibitor) and pembrolizumab in metastatic pancreatic cancer with translational immune profiling 一项XL888（HSP90抑制剂）与pembrolizumab联合治疗转移性胰腺癌的Phase Ib/II临床试验，并进行转化性免疫谱分析

Cancer Letters

IF10.1

2025-12-23

OAAI

Natalie K. Horvat; Maria Diab; Maggie J. Phillips; Ashley Veal-McCook; Erin E. Grundy; Olatunji B. Alese; Emily Greene; Olumide Gbolahan; Kathleen Coleman; Deon Doxie; Cameron J. Herting; Jacklyn Hammons; Zaid Mahdi; Jeffrey M. Switchenko; Chrystal M. Paulos; Bassel F. El-Rayes; Gregory B. Lesinski

Real-World Impact of Metformin on Outcomes in Patients with Deficient DNA Mismatch Repair and Microsatellite Instability (dMMR/MSI) Colorectal Cancer Treated with Immune Checkpoint Inhibitors 二甲双胍对接受免疫检查点抑制剂治疗的患者中DNA错配修复缺陷和微卫星不稳定性(dMMR/MSI)结直肠癌结局的实时世界影响

Cancers 2025, Vol. 17, Page 3944

IF4.4

2025-12-10

OAAI

Garima Gupta; Negar Sadeghipour; Fuat Bicer; Andrew Elliott; Andrew Hinton; Emil Lou; Ari M. Vanderwalde; Ahmet Anil Ozluk; Moh’d M. Khushman; Midhun Malla; Darryl Outlaw; Syed Qasim Hussaini; Bassel F. El-Rayes; Mehmet Akce

Optimized dose schedule of rucaparib and liposomal irinotecan/5-fluorouracil in metastatic gastrointestinal cancers: A phase 1 study rucaparib和脂质体伊立替康/5-氟尿嘧啶在转移性消化道肿瘤中的优化给药方案：一项1期研究

Cancer

IF5.1

2025-11-22

PREAI

Cody Eslinger MD, MS; Daniel Walden MD; Alexandra Krivonos BS; Numrah Fadra PhD; Tyler Zemla MS; Wen Wee Ma MBBS; Bassel El-Rayes MD; Olatunji Alese MD; Thorvardur Halfdanarson MD; Timothy Hobday MD; Sarah Bruggeman BS; Brandy Jaszewski BS; Fang-Shu Ou PhD; Mohamad Bassam Sonbol MD; Daniel Ahn DO; Mitesh J. Borad MD; Christina Wu MB, BCh, MD; Robert McWilliams MD; Tanios Bekaii-Saab MD

Emerging therapeutic advancements in pancreatic cancer: a contemporary review 胰腺癌新兴治疗进展：当代综述

Discover Oncology

IF2.9

2025-10-15

OAAI

Midhun Malla; Yara Sakr; Garima Gupta; Mehmet Akce; Bassel El-Rayes

HER2 alterations across solid tumors: implications for comprehensive testing HER2变异在实体瘤中的分布：全面检测的意义

ONCOLOGIST

IF4.2

2025-09-01

OAAI

Ismail, Ahmed; Jani, Chimay; Jahan, Nusrat; Midhun, Malla; Basu, Arnab; Gupta, Garima; El-Rayes, Bassel; Bae, Sejong; Mattox, Tyler; Hawkins, Cyntanna; Arend, Rebecca C.; Akce, Mehmet; Boumber, Yanis; Desai, Aakash

Phase I trial of ADP-A2AFP TCR T-cell therapy in patients with advanced hepatocellular or gastric hepatoid carcinoma I期ADP-A2AFP TCR T细胞疗法在晚期肝细胞癌或胃肝样腺癌患者中的临床试验

Journal of Hepatology

IF33

2025-08-12

PREAI

Tim Meyer; Richard S. Finn; Mitesh Borad; Amit Mahipal; Julien Edeline; Roch Houot; Petr F. Hausner; Antoine Hollebecque; Lipika Goyal; Matthew Frigault; Thomas R. Jeffry Evans; Kit Man Wong; Benjamin R. Tan; Emmanuel Mitry; Debashis Sarker; Lynn Feun; Bassel El-Rayes; Fiona Thistlethwaite; Ahmed Kaseb; Olatunji Alese

CRISPR/Cas9-directed epigenetic editing in colorectal cancer CRISPR/Cas9介导的结直肠癌表观遗传编辑

biochimica et biophysica acta reviews on cancer

IF0

2025-04-30

PREAI

Manoj Kumar Gupta; Gayatri Gouda; Maryam Moazzam-Jazi; Ramakrishna Vadde; Ganji Purnachandra Nagaraju; Bassel F. El-Rayes

XL888 and pembrolizumab modulate the immune landscape of colorectal tumors in a phase Ib/II clinical trial XL888和pembrolizumab在Ib/II期临床试验中调节结直肠癌的免疫景观。

OncoImmunology

IF6.3

2025-03-13

OAAI

Maggie J. Phillips; Olatunji B. Alese; Natalie K. Horvat; Emily Greene; Olumide B. Gbolahan; Kathleen Coleman; Deon B. Doxie; Vaunita Parihar; Zaid K. Mahdi; Ashley McCook-Veal; Jeffrey M. Switchenko; Maria Diab; Cameron J. Herting; Chrystal M. Paulos; Bassel F. El-Rayes; Gregory B. Lesinski

Mechanism of enhancing chemotherapy efficacy in pancreatic ductal adenocarcinoma with paricalcitol and hydroxychloroquine 使用帕立骨化醇和羟氯喹增强胰腺导管腺癌化疗疗效的机制

CELL REPORTS MEDICINE

IF10.6

2025-01-01

OAAI

Nagaraju, Ganji Purnachandra; Saddala, Madhu Sudhana; Foote, Jeremy B.; Khaliq, Ateeq M.; Masood, Ashiq; Golivi, Yuvasri; Bandi, Dhana Sekhar Reddy; Sarvesh, Sujith; Reddy, Sudhir Putty; Switchenko, Jeffrey; Carstens, Julienne L.; Akce, Mehmet; Herting, Cameron; Alese, Olatunji B.; Yoon, Karina J.; Manne, Upender; Bhasin, Manoj K.; Lesinski, Gregory B.; Sukhatme, Vikas P.; El-Rayes, Bassel F.

RCC1 regulation of subcellular protein localization via Ran GTPase drives pancreatic ductal adenocarcinoma growth

CANCER LETTERS

IF10.1

2024-11-01

PREAI

Bannoura, Sahar F.; Aboukameel, Amro; Khan, Husain Yar; Uddin, Md Hafiz; Jang, Hyejeong; Beal, Eliza W.; Thangasamy, Amalraj; Shi, Yang; Kim, Seongho; Wagner, Kay-Uwe; Beydoun, Rafic; El-Rayes, Bassel F.; Philip, Philip A.; Mohammad, Ramzi M.; Saif, Muhammad Wasif; Al-Hallak, Mohammed Najeeb; Pasche, Boris C.; Azmi, Asfar S.

A novel pan-RAS inhibitor (ADT-1004) with superior efficacy over mutation-specific KRAS inhibitors in mouse models of pancreatic cancer

EUROPEAN JOURNAL OF CANCER

IF7.1

2024-10-01

PREAI

Bandi, D. S. R.; Nagaraju, G. P.; Foote, J. B.; Keeton, A.; Chen, X.; Berry, K. L.; Maxuitenko, Y. Y.; Manne, U.; Buchsbaum, D. J.; Piazza, G. A.; El-Rayes, B. F.

Survival benefit and tumor regression with a dual RAS/β-catenin inhibitor, ADT-030, in murine models of pancreatic and lung cancer

EUROPEAN JOURNAL OF CANCER

IF7.1

2024-10-01

PREAI

Bandi, D. S. R.; Nagaraju, G. P.; Foote, J. B.; Keeton, A.; Chen, X.; Berry, K. L.; Maxuitenko, Y. Y.; Manne, U.; Buchsbaum, D. J.; Piazza, G. A.; El-Rayes, B. F.

A novel pan-RAS/ β-catenin inhibitor, ADT-030, produces tumor regression in PDX models of pancreatic cancer

CANCER RESEARCH

IF16.6

2024-09-15

PREAI

Bandi, Dhana Sekhar Reddy; Nagaraju, Ganji P.; Foote, Jeremy B.; Keeton, Adam B.; Chen, Xi; Berry, Kristy L.; Maxuitenko, Yulia Y.; Manne, Upender; Buchsbaum, Donald J.; Piazza, Gary A.; El-Rayes, Bassel F.

Efficacy advantages of a novel pan-RAS inhibitor, ADT-1004, over mutant- specific KRAS inhibitors for suppressing pancreatic tumor growth in murine models

CANCER RESEARCH

IF16.6

2024-09-15

PREAI

Association between frailty and overall survival among older adults with hepatocellular carcinoma

JOURNAL OF GERIATRIC ONCOLOGY

IF2.7

2024-09-01

PREAI

Ozluk, Ahmet Anil; Williams, Grant Richard; Dai, Chen; Goldberg, Jonathan; Malla, Midhun; Pywell, Cameron; Siwakoti, Krishmita; Outlaw, Darryl Alan; Gupta, Garima; El-Rayes, Bassel; Giri, Smith; Akce, Mehmet

Mesothelin expression correlates with elevated inhibitory immune activity in patients with colorectal cancer

CANCER GENE THERAPY

IF5

2024-08-22

OAAI

Malla, Midhun; Deshmukh, Sachin Kumar; Wu, Sharon; Samec, Timothy; Olevian, Dane C.; El Naili, Reima; El-Rayes, Bassel; Xiu, Joanne; Farrell, Alex; Lenz, Heinz-Josef; Lou, Emil; Goel, Sanjay; Spetzler, David; Goldberg, Richard M.; Hazlehurst, Lori

Nivolumab plus ipilimumab combination therapy in patients with advanced hepatocellular carcinoma previously treated with sorafenib: 5-year results from CheckMate 040 Nivolumab联合ipilimumab治疗先前接受索拉非尼治疗的晚期肝细胞癌患者: CheckMate 040的5年结果

ANNALS OF ONCOLOGY

IF65.4

2024-06-01

OAAI

Melero, I.; Yau, T.; Kang, Y. -K.; Kim, T. -Y.; Santoro, A.; Sangro, B.; Kudo, M.; Hou, M. -M.; Matilla, A.; Tovoli, F.; Knox, J.; He, A. R.; El-Rayes, B.; Acosta-Rivera, M.; Lim, H. Y.; Soleymani, S.; Yao, J.; Neely, J.; Tschaika, M.; Hsu, C.; El-Khoueiry, A. B.

研究方向